Valuation Celemics, Inc.

Stocks

End-of-day quote Korea S.E. 21/09/2026			5-day change	1st Jan Change
10,860.00 ^KRW	-3.89%		-15.09%	+300.00%

24/06	Celemics, Inc. announced that it expects to receive KRW 9.9999956 billion in funding from Cnp Co., Ltd.	CI
29/05	Celemics, Inc. announced that it has received KRW 11.5999945 billion in funding	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024	2025
Market Cap ¹	47,352	34,534	26,738	22,166
Change	-	-27.07%	-22.58%	-17.1%
Enterprise Value (EV) ¹	35,738	24,706	17,189	16,626
Change	-	-30.87%	-30.42%	-3.28%
P/E	-9.86x	-8.91x	2.19x	-5.49x
PBR	2.55x	2.17x	0.98x	0.96x
PEG	-	0.5x	-0x	0x
Capitalization / Revenue	5.42x	5.25x	3.98x	3.84x
EV / Revenue	4.09x	3.76x	2.56x	2.88x
EV / EBITDA	-7.38x	-5.03x	-15.5x	-6.38x
EV / EBIT	-6.23x	-4.28x	-9.03x	-5x
EV / FCF	-	-	-	-
FCF Yield	-	-	-	-
Dividend per Share ²	-	-	-	-
Rate of return	-	-	-	-
EPS ²	-588	-475	1,493	-494.4
Distribution rate	-	-	-	-
Net sales ¹	8,729	6,578	6,719	5,768
EBITDA ¹	-4,840	-4,914	-1,111	-2,604
EBIT ¹	-5,734	-5,770	-1,903	-3,324
Net income ¹	-4,797	-3,876	12,266	-4,036
Net Debt ¹	-11,614	-9,828	-9,548	-5,540
Reference price ²	5,800.00	4,230.00	3,275.00	2,715.00
Nbr of stocks (in thousands)	8,164	8,164	8,164	8,164
Announcement Date	20/3/24	20/3/24	19/3/25	23/3/26

¹KRW in Million²KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CELEMICS, INC.	-	-	-	-	88.33M
LONZA GROUP AG	32.07x	5.77x	17.28x	1.01%	46.68B
IQVIA HOLDINGS INC.	34.76x	3.35x	14.44x	-.--%	44.42B
REVOLUTION MEDICINES, INC.	-19.81x	213.44x	-21.53x	-.--%	41.32B
BEONE MEDICINES AG	47.9x	5.56x	30.41x	-.--%	41.58B
CELLTRION, INC.	27.45x	7.91x	20.36x	0.41%	30.14B
MEDPACE HOLDINGS, INC.	35.5x	5.83x	26.48x	-.--%	17.42B
EUROFINS SCIENTIFIC SE	26.02x	2.23x	9.67x	1.03%	15.54B
TEMPUS AI, INC.	-56.03x	9.2x	224.52x	-.--%	14.08B
Average	15.98x	31.66x	40.20x	0.31%	27.92B
Weighted average by Cap.	21.00x	39.70x	24.72x	0.3%